[Sildenafil in neonate pulmonary hypertension: the opinion of neonatology physician].
Condò
V
V
U.O. Neonatologia, Ospedale San Giuseppe, Università degli Studi, Milano.
Colnaghi
M R
MR
Mosca
E
E
D000280:Administration, Inhalation; D000284:Administration, Oral; D001993:Bronchodilator Agents / Q000008:administration & dosage; D002352:Carrier Proteins / Q000187:drug effects* / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D007231:Infant, Newborn; D007275:Injections, Intravenous; D047908:Intracellular Signaling Peptides and Proteins / Q000187:drug effects* / Q000378:metabolism; D009359:Neonatology; D009569:Nitric Oxide / Q000008:administration & dosage; D010879:Piperazines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011687:Purines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*
D001993:Bronchodilator Agents; D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; C022994:cyclic GMP-binding protein; D009569:Nitric Oxide; D000068677:Sildenafil Citrate